BIO-TECHNE CORP. DL-01/ US09073M1045 /
| 07/11/2024 07:57:06 | Chg. -2.5000 | Volume | Bid19:25:35 | Ask19:25:35 | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 71.0000EUR | -3.40% | - Turnover: - |
70.5000Bid Size: 160 | 71.0000Ask Size: 160 | 11.34 bill.EUR | - | - |
Fundamentals
| FY 2024 | Growth (1Y) | |
|---|---|---|
| Per Share | ||
| Earnings per Share: | 1.07 USD | -40.88% |
| EPS Diluted: | 1.05 USD | -40.34% |
| Revenues per Share: | 7.31 USD | 1.69% |
| Book Value per Share: | 13.04 USD | 4.92% |
| Cash Flow per Share: | 1.89 USD | 17.21% |
| Dividend per Share: | 0.32 USD | 0.00% |
| Total | in mill. | |
| Revenues: | 1,159.06 USD | 1.97% |
| Net Income: | 168.11 USD | -41.07% |
| Operating Cash Flow: | 298.98 USD | - |
| Cash and Cash Equivalents: | 151.79 USD | - |
Valuation Ratios
| Current | Latest FY* | |
|---|---|---|
| P/E Ratio: | 71.58 | 66.96 |
| P/S Ratio: | 10.48 | 9.80 |
| P/BV ratio: | 5.87 | 5.49 |
| P/CF Ratio: | 40.63 | 38.01 |
| PEG: | -1.75 | -1.64 |
| Earnings Yield: | 1.40% | 1.49% |
| Dividend Yield: | 0.42% | 0.45% |
| Market Capitalization | ||
| Market Capitalization: | 11.34 bill. EUR | 10.59 bill. EUR |
| Free Float Market Cap.: | - EUR | - EUR |
| Market Cap. / Employee: | - EUR | - EUR |
| Shares Outstanding: | 158.6 mill. | |
Profitability
| Gross Profit Margin: | 66.41% |
| EBIT Margin: | 17.83% |
| Net Profit Margin: | 14.50% |
| Return on Equity: | 8.13% |
| Return on Assets: | 6.22% |
Financial Strength
| Liquidity I / Cash Ratio: | 0.95% |
| Liquidity II / Quick Ratio: | 2.47% |
| Liquidity III / Current Ratio: | 3.87% |
| Debt / Equity Ratio: | 0.15% |
| Dynam. Debt / Equity Ratio: | 212.39% |
Efficiency
| Employees: | - |
| Personal Expenses / Employee: | - USD |
| Revenues / Employee: | - USD |
| Net Income / Employee: | - USD |
| Total Assets / Employee: | - USD |
| * Fiscal Year End: | 30/06/2024 |
| Accounting Standard: | US GAAP |
| Currency: | USD |
